Photodynamic therapy (PDT) is a treatment for cancer and several noncancerous proliferating cell diseases that depends on the uptake of a photosensitizing compound followed by selective irradiation with visible light. In the presence of oxygen, irradiation leads to the production of reactive oxygen species (ROS). A large production of ROS induces the death of cancer cells by apoptosis or necrosis. A small ROS production can activate various cellular pathways. Here, we show that PDT by pyropheophorbide-a methyl ester (PPME) induces the activation of nuclear factor kappa B (NF-jB) in HMEC-1 cells. NF-jB is active since it binds to the NF-jB sites of both ICAM-1 and vascular cell adhesion molecule-1 (VCAM-1) promoters and induces the transcription of several NF-jB target genes such as those of IL-6, ICAM-1, VCAM-1. In contrast, expression of ICAM-1 and VCAM-1 at the protein level was not observed, although we measured an IL-6 secretion. Using specific chemical inhibitors, we showed that the lack of ICAM-1 and VCAM-1 expression is the consequence of their degradation by lysosomal proteases. The proteasome and calpain pathways were not involved. All these observations were consistent with the fact that no adhesion of granulocytes was observed in these conditions.
Introduction
Photodynamic therapy (PDT) is a minimally invasive treatment for cancer and noncancerous proliferating cell diseases that relies on the uptake of a photosensitizing compound by the pathologic tissue followed by selective irradiation with visible light (Dougherty et al., 1998; Dougherty, 2002) . In the presence of oxygen, the irradiation process leads to the production of reactive oxygen species (ROS) that have been shown to be important for the success of the treatment. Recently, PDT also appeared as an interesting tool in treating endothelial cells associated with pathologies since they are important in neovascularization, which is known to occur in the formation of atherosclerotic plaques, proliferative retinopathies, and malignant neoplasias (Aiello, 1997; Carmeliet and Jain, 2000; Yancopoulos et al., 2000) . For example, PDT has been shown to be effective and safe in the treatment of choroidal neovascularization secondary to age-related macular degeneration (Schmidt-Erfurth, 1998; Woodburn et al., 2002) and in the elimination of neovascularized tumours (Henderson et al., 1995) . The tumour-associated microvasculature, specifically endothelial cells and the vascular basement membrane, is a very important target for PDT because it induces damage to this structure and leads to the establishment of thrombogenic sites within the vessel lumen (Krammer, 2001) . With a high dose of PDT, endothelial cells can undergo apoptosis and/or necrosis depending on the nature of the photosensitizer used (Marcinkowska et al., 2001; Chen et al., 2002) , but can also trigger an inflammatory and immune response (Korbelik, 1996) . With a low dose of PDT, ROS could induce the activation of several transduction pathways in endothelial cells, such as nuclear factor kappa B (NF-kB) pathway (Volanti et al., 2002) .
It has been largely demonstrated that PDT induces a high inflammatory response at the treated site and a rapid and intense neutrophil recruitment (Krosl et al., 1995) . This inflammatory process is very important for the efficiency of the treatment and the eradication of the tumour. Endothelial cells play a crucial function in neutrophil recruitment through expression of cellular adhesion molecules such as CAMs, intregins and selectins (Wagner and Roth, 2000) .
An important element for the success of the PDT is the nature of the photosensitizer. Actually, the only drug approved for tumour therapy is Photofrin which is highly effective. However, it exhibits several drawbacks (Sharman et al., 1999) . New photosensitizers have since been developed and a number of new agents are now in clinical trials (Sharman et al., 1999) . Several groups have recently reported the antitumour effectiveness of pheophorbide-and pyropheophorbide-based PDT (Bellnier et al., 1993; Payne et al., 1996; Henderson et al., 1997) . These compounds are chemically well characterized, absorb light above 600 nm, and produce less longterm phototoxicity for normal tissue than Photofrin. In this work, we used pyropheophorbide-a methyl ester (PPME), which has been shown to localize in the cytoplasmic membrane, in lysosomes, and in the endoplasmic reticulum (ER) (Matroule et al., 1999) . As NF-kB is probably the most important transcription factor for the inflammatory response (Karin and Ben Neriah, 2000) , we decided to investigate the physiological consequences of NF-kB activation induced by PDT. Since the inflammatory response associated with PDT and mediated by leukocytes is essential for the outcome of the therapy, we decided to study the transcription and expression of several NF-kB-dependent adhesion molecules after PDT of the HMEC-1 cells.
Results

PDT induces the transcription of several inflammatory genes in endothelial cells
As the transcription of genes encoding adhesion molecules is an important event in the inflammatory response mediated by endothelial cells, we decided to investigate whether PDT of endothelial cells could induce ICAM-1, vascular cell adhesion molecule-1 (VCAM-1), E-Selectin gene transcription and IL-6, an inflammatory cytokine. RNAs of HMEC-1 cells treated by PDT were extracted and subjected to RT-PCR analysis. As shown in Figure 1a , PDT induces the transcription of several genes, such as ICAM-1, VCAM-1 and IL-6, but not E-selectin. RNAs were detectable as early as 1 h after the irradiation and were still detectable after 24 h. The maximum intensity is dependent on the gene analysed ( Figure 1b) . These experiments confirmed that PDT could induce the transcription of several inflammatory genes, particularly adhesion molecules ICAM-1, VCAM-1 and the inflammatory cytokine IL-6. NF-kB is an important transcription factor in ICAM-1 and VCAM-1 gene transcription induced by PDT Since genes encoding adhesion molecules are under the control of the transcription factor NF-kB and we previously showed that PPME-mediated PDT of endothelial cells induced the activation of NF-kB (Volanti et al., 2002) , we decided to demonstrate the role of NF-kB in the transcription of gene encoding ICAM-1 and VCAM-1 after PDT treatment of endothelial cells. The ICAM-1 promoter contains two NF-kB binding sites: a proximal located at about 200 bp upstream of the translation initiation site and a more distal one. The proximal site has been demonstrated to be particularly important in the induction of ICAM-1 transcription . The VCAM-1 promoter also contains a functional cis regulatory sequence, which depends on NF-kB binding. We investigated whether NF-kB induced by PPME photosensitization was able to bind the NF-kB sites of both ICAM-1 and VCAM-1 promoters. HMEC-1 cells were photosensitized with 5 mM PPME and an irradiation of 2 J/cm 2 . At various times after irradiation, nuclear extracts were prepared and subjected to an electrophoretic mobility shift assay (EMSA) with specific probes for ICAM-1 distal and proximal NF-kB binding sites or for VCAM-1 NF-kB binding site. The specificity of the retarded bands observed was controlled by competition with wild-type nonradiolabelled probes (data not shown). As shown in Figure 2a Figure 1 Transcriptional analysis of genes encoding ICAM-1, VCAM-1 and IL-6 genes after PDT. HMEC-1 cells were either treated by PDT (5 mM PPME, 2 J/cm 2 red light irradiation), TNF-a (200 U/ml) or LPS (10 mg/ml). Control cells incubated with PPME (5 mM) but not irradiated are noted Ctrl. Control cells irradiated without PPME are noted hu. Total RNAs were isolated at various times after treatment. RNAs were analysed by RT-PCR with specific primers for ICAM-1, VCAM-1, E-selectin, IL-6 and GAPDH. promoter and of the VCAM-1 promoter. We never detected a binding to the ICAM-1 NF-kB distal site after either PDT, lipopolysacharide (LPS) or tumour necrosis factor-a (TNF-a) treatment (data not shown). NF-kB binding onto the ICAM-1 proximal site occurred after 30 min and was maximal at 6 h. After 24 h, NF-kB activation was identical to that of the untreated cells (data not shown). Binding to the VCAM-1 promoter followed the same kinetics with a small delay since it occurred after 1 h. Two specific bands were observed for ICAM-1 and VCAM-1 as well. Supershift experiments demonstrated that at least one of the bands was composed by the classical dimer of the Rel/NF-kB family member: p50/p65 (Figure 2b ). To test the importance of NF-kB in the ICAM-1 transcription induction, we transiently transfected the cells either with a luciferase reporter gene under the control of the ICAM-1 wild-type promoter, or with a luciferase reporter gene under the control of the ICAM-1 promoter mutated on the NF-kB binding sites. Cells were photosensitized and luciferase activity was measured in cell extracts 8 h after treatment. As shown in Figure 2c , PDT and classical NF-kB inducers, such as TNFa or LPS, stimulated respectively 1.8-, 3.8-and 3.5-fold the luciferase activity when the cells were transfected with the ICAM-1 promoter construct. No induction of the luciferase activity was observed when cells were transfected with the ICAM-1 mutated promoter construct. These experiments demonstrated that NF-kB plays a major role in the trancription of ICAM-1 and VCAM-1 after PDT.
PDT does not induce the expression of ICAM-1 and VCAM-1 proteins After having shown that PDT mediated by PPME induced the transcription of ICAM-1 and VCAM-1, we tried to visualize the expression of the corresponding proteins. We investigated the expression of ICAM-1 and VCAM-1 by Western blotting and immunofluorescence. Although TNF-a and LPS treatment induced a high ICAM-1 and VCAM-1 expression, PDT mediated by PPME did not induce the expression of these two proteins ( Figure 3a ). This absence of expression is not due to a cytotoxic effect of the treatment since survival was around 95% (Volanti et al., 2002) . As this absence of adhesion molecule expression after PDT mediated by PPME could be a special feature associated with its subcellular localization (ER membranes and Golgi), we decided to test another photosensitizer in similar conditions. We turned to Photofrin because it was shown to be associated with mitochondria. Cells were then incubated overnight with Photofrin (10 mg/ml) and irradiated at 1 J/cm 2 . At 6 h after irradiation, protein were extracted and analysed by Western blotting. As shown in Figure 3a , Photofrin photosensitization induces ICAM-1 and VCAM-1 expression. These results suggested that the observed lack of adhesion molecule expression is specific to PPME. HMEC-1 cells were also cultivated and treated on coverslips, then fixed and analysed by immunofluorescence after either 12 or 24 h 2 red light irradiation of HMEC-1 cells preincubated with 5 mM PPME or after classical NF-kB inducers treatment (TNF-a (200 U/ml); LPS (10 mg/ml)). Control cells incubated with PPME (5 mM) but not irradiated are noted Ctrl. Nuclear extracts were prepared at various times after the treatment and 5 mg of protein were mixed with 32 P-labeled kB probes. Probes are specific for two NF-kB binding sites of the ICAM-1 promoter (distal and proximal sites) and for the NF-kB binding site of the VCAM-1 promoter. The autoradiograms of the gels are shown. The arrows indicate the position of the specific complex. The nonspecific DNA binding is noted n.s. (b) Supershift experiment, nuclear extracts of HMEC-1 cells treated by PDT were prepared 6 h after irradiation and incubated with specific antibodies for p65, p50, cRel, RelB and p52 before being mixed with specific radiolabelled probes for the NF-kB proximal binding site of ICAM-1 promoter and the NF-kB binding site of VCAM-1 promoter. (c) Transient transfection assay of HMEC-1 cells with a Luciferase reporter gene under the control of the ICAM-1 promoter (filled bars) or with Luciferase reporter gene under the control of the ICAM-1 promoter mutated on the two NF-kB sites (hatched bars). Cells were untransfected (noted U) or transfected with 1 mg of DNA for 24 h are either left untreated (noted ctrl), or treated with TNF-a (200 U/ml), with LPS (10 mg/ml) or photosensitized with PPME (5 mM) and a 2 J/cm 2 red light irradiation. Cell lysates were prepared 8 h after the treatment and directly analysed. For each condition, the luciferase activity was normalized by the amount of protein.
Results are expressed as fold induction of the luciferase activity measured in the cells transfected but left untreated Photodynamic therapy on endothelial cells C Volanti et al ( Figure 3b ). The fluorescence observed after PDT mediated by PPPME treatment was similar to the background fluorescence of the untreated cells. On the other hand, when the cells were treated with either TNF-a or LPS, an important fluorescence was detected. These data suggest that PDT inhibited either ICAM-1 and VCAM-1 translation or their export pathway. In addition, we tested whether PDT could interfere with ICAM-1 induced by TNF-a or LPS treatment. HMEC-1 cells were photosensitized with PPME and then treated by TNF or LPS directly after the irradiation. The cells were lysed 12 h after the treatment and protein extract were analysed by Western blotting. As shown in Figure 3c , pretreatment by PDT strongly decreases the level of ICAM-1 expression compared to the non-PDT pretreated cells. These experiments confirmed that PDT mediated by PPME could interfere with the expression of these proteins.
PDT does not disturb the translation machinery
In order to investigate whether PDT mediated by PPME interfere with the translation machinery, we followed the release of IL-6. HMEC-1 cells were photosensitized and aliquots of culture medium were collected at various times after irradiation. IL-6 release was measured by ELISA assay. As shown in Figure 4 , IL-6 concentration increases gradually up to 48 h after PDT, demonstrating that PDT does not interfere with the protein translation machinery.
ICAM-1 and VCAM-1 are degraded in lysosomes
As the alteration of the translation machinery was not the obvious cause of the nonexpression of the adhesion molecules, we suspected that ICAM-1 and VCAM-1 could be degraded before being correctly targeted at the plasma membrane. To investigate this hypothesis, we decided to test the involvement of different protein degradation pathways. Three major protein degradation mechanisms were investigated: 26S proteasome, calpain and lysosome pathways. HMEC-1 cells were photosensitized and incubated after irradiation with specific inhibitors of the proteasome pathway (MG 132), the calpain and proteasome pathway (ALLN) and the lysosome pathway (Leupeptin, pepstatin A and E64). Proteins extracts were then taken at various times after irradiation and analysed for ICAM-1 (Figure 5a ) and VCAM-1 (Figure 5b ) expression by Western blotting. As shown in Figure 5a and b, the inhibition of the proteasome and calpain degradation pathways does not restore expression of ICAM-1 or VCAM-1 after PDT. HMEC-1 cells were untreated (T-), treated by PDT (5 mM PPME, 2 J/cm 2 red light irradiation), treated by TNF-a (200 U/ml) or treated by LPS (10 mg/ml). Cells were fixed and permeabilized at various times after the treatment. Fixed cells were subjected to an immunofluorescence experiment with specific antibodies against ICAM-1 or VCAM-1. Fluorescence detection was carried out by epifluorescence microscopy. (c) HMEC-1 cells were either untreated, treated by TNF-a (200 U/ml), treated by LPS (10 mg/ml), treated by PDT (5 mM PPME, 2 J/cm 2 red light irradiation), or treated by PDT (5 mM PPME, 2 J/cm 2 red light irradiation) and directly after the irradiation treated by TNF-a (200 U/ml) or LPS (10 mg/ml). Control cells incubated with PPME (5 mM) but not irradiated are noted Ctrl. After 12 h, cell lysates were prepared and analysed by Western blot with an antibody specific for ICAM-1. l.c. represents the loading control PDT induces the release of IL-6. IL-6 released by HMEC-1 cells treated by TNF-a (200 U/ml), LPS (10 mg/ml) or PDT (5 mM PPME, 2 J/cm 2 red light irradiation). Control cells incubated with PPME (5 mM) but not irradiated are noted Ctrl. Aliquots of the culture medium were taken at various times after the treatment, frozen at À801C and then analysed by ELISA Photodynamic therapy on endothelial cells C Volanti et al However, incubation of HMEC-1 cells with inhibitors of lysosomal proteases restored the expression of both ICAM-1 and VCAM-1 as early as 12 h after the irradiation. The expression of the two proteins was specific of PDT mediated by PPME since untreated cells incubated with pepstatin A, leupeptin and E64 did not express ICAM-1 or VCAM-1 at any time. To definitively clarify a possible role of the proteasome in the ICAM-1 protein degradation after PDT, we tried to visualize ICAM-1 ubiquitination in PDT-treated HeLa cells transfected with constructs expressing ICAM-1 fused to EGFP and ubiquitin-HA tagged. However, we failed to demonstrate any ICAM-1 ubiquitination after PDT by immunoprecipitating ICAM-1 and Western blotting against HA-ubiquitin (data not shown). Identical results were obtained using a mono-ubiquitin-HA tagged construct (data not shown). For further confirmation of the involvement of lysosomes in ICAM-1 degradation after PDT, HeLa cells were transfected by the ICAM-1-EGFP fusion construct and analysed by confocal laser microscopy with or without inhibitors of lysosomal proteases. The lysosomes were stained by the LysoTracker red. As shown in Figure 6 (panels a-c), ICAM-1-EGFP was mainly located at the plasma membrane in untreated cells and lysosomes were homogenously distributed in the cytoplasm. After PDT, ICAM-1 expression could not be detected at the plasma membrane in the absence of lysosomal protease inhibitors, whereas intracytoplasmic structures containing ICAM-1-EGFP were observed ( Figure 6, panels d and f) . In addition, the ICAM-1 expression level was strongly decreased in these conditions. It is worth noting that lysosomes were spatially redistributed to converge into confined compartments in the cytoplasm (Figure 6 , panel e). The overlay between images of ICAM-1-EGFP and lysosomes unambiguously showed that they are both confined in the same cytosolic compartments (Figure 6 , panel f). If HeLa cells were pretreated with specific inhibitors of lysosomal proteases after PDT, a restoration of the classical plasma membrane localization of ICAM-1-EGFP could be observed with a level of expression similar to the untreated cells ( Figure 6 , panel g). These experiments strongly reinforced our hypothesis of a degradation of ICAM-1 in lysosomes after PDT mediated by PPME.
Intracellular membrane oxidation mediated by PDT drive ICAM-1 degradation
As PPME was shown to induce oxidative stress and to localize in the intracellular membrane (ER and Golgi), we investigated the role of membrane oxidation in ICAM-1 degradation. HMEC-1 cells were treated with two membrane-specific antioxidants, a-tocopherol acetate and butylated hydroxyanisole (BHA), alone or in combination. As it was shown that pretreatment by antioxidants could block the NF-kB activation induced by PPME photosensitization (Volanti et al., 2002) , cells were incubated with BHA and a-tocopherol acetate 4 h after the irradiation. As shown in Figure 7a , treatment with BHA alone or in combination with a-tocopherol acetate restored the expression of ICAM-1 either 24 or 48 h after PDT, suggesting that oxidative stress could be the initial event that interferes with correct ICAM-1 plasma membrane targeting. In order to confirm this hypothesis, HMEC-1 cells were treated 4 h after PDT with butylated hydroxytoluene (BHT, 50 mM), a classical chain-breaking antioxidant, or with 3,5-di-tert-butyltoluene (DBT, 50 mM) a nonphenolic analogue of BHT used as a control (Niziolek et al., 2003) . As shown in Figure 7b , treatment with BHT restored ICAM-1 protein expression from at least 8 h up to 36 h after PDT, while treatment with DBT had no effect. These data strongly support the role of PPME-mediated lipoperoxidation in ICAM-1 degradation.
Neutrophils do not adhere to PPME treated HMEC-1 cells
Since it has been reported several times that PDT induced a large and rapid recruitment of neutrophils in . Directly after treatment, cells were incubated with a cocktail of inhibitor of lysosomal protease (pepstatin A 1 mM, E64 5 mM, leupeptin, 10 mM). At 6 h after treatment, cells were incubated with an inhibitor of the 26S proteasome (MG 132 10 mM) or with an inhibitor of the 26S proteasome and calpain (ALLN 100 mM). Control cells incubated with PPME (5 mM) but not irradiated are noted Ctrl. Cell lysates were prepared at various times after the treatment. In total, 20 mg of proteins were analysed by Western blot with (a) specific antibodies for ICAM-1 and (b) specific antibodies for VCAM-1. l.c. represents the loading control Photodynamic therapy on endothelial cells C Volanti et al the tumour treated site (Krosl et al., 1995; Dougherty et al., 1998) , we decided to check whether PPME mediated PDT could induce the adhesion of neutrophils on endothelial cells. Briefly, HMEC-1 cells were photosensitized, 12 h after irradiation cells were cultured for 1 h in the presence of an excess of human granulocytes (10 granulocytes per endothelial cell). Cells were washed, trypsinized to ensure a total dissociation and then analysed by FACS. As shown in Figure 8 , PDT mediated by PPME does not induce granulocyte adhesion, while LPS treatment induced a high adhesion. Surprisingly, TNF-a treatment induced only a much lower adhesion than LPS. To confirm the involvement of the lysosomal proteolysis pathway in PDT induced adhesion molecule degradation, HMEC-1 cells were treated with lysosomal protease inhibitors. This treatment partially restores adhesion of granulocytes ( Figure 8 ). As we showed that Photofrin mediated PDT induced ICAM-1 and VCAM-1 expression, we subjected HMEC-1 cells to a granulocyte adhesion assay after Photofrin photosensitization. Although no adhesion was observed after PDT mediated by PPME, Photofrin photosensitization of HMEC-1 cells induced a granulocyte adhesion whose level was about equivalent to that of TNF-a.
Discussion
Tumour eradication by PDT is complex and not yet fully understood. PDT acts at least on three different pathways by inducing (i) a direct tumour cell death by apoptosis or necrosis (Oleinick and Evans, 1998), (ii) vascular damage leading to severe tumour hypoxia or anoxia (Schreiber et al., 2002) , and (iii) an inflammatory and immunological response against the tumour (Korbelik, 1996) . It is highly likely that a combination of these three mechanisms is involved in tissue destruction (Dougherty et al., 1998) . Recently, the idea has emerged that the most important parameter for the success of PDT is vascular damage. The inflammatory response associated with the treatment is also very important since it induces neutrophil infiltration and is the first step for the establishment of an immunological response leading to a long-term tumour elimination (Schreiber et al., 2002) . Endothelial cells play a pivotal role in vascular damage as well as in inflammation. Determining the molecular effects of PDT on endothelial cells is thus of primary importance to improving our knowledge on tumour elimination by PDT.
The most important step leading to the establishment of inflammation after PDT is unambiguously the rapid Figure 6 ICAM-1 degradation and lysosomes redistribution after PDT. HeLa cells transiently transfected with pBJ1 neo ICAM-1-EGFP were untreated (panels a-c) or treated by PDT (5 mM PPME, 2 J/cm 2 red light irradiation) with (panels g-i) or without (panels d-f) a preincubation of 1 h with a cocktail of inhibitor of lysosome proteases (pepstatin A 1 mM, E64 5 mM, leupeptin 10 mM). Lysosomes were dyed by LysoTracker red. At 6 h after the irradiation, cells were fixed and analysed by confocal laser microscopy. Green fluorescence is representative of ICAM-1-GFP and red fluorescence is representative of lysosomes. Arrows indicate cytoplasmic compartments containing both ICAM-1-GFP and lysosomes. The side of each panel corresponds to 80 mm Photodynamic therapy on endothelial cells C Volanti et al and massive invasion of the treated site by neutrophils.
de Vree et al. (1996) have shown that the efficacy of PDT was dependent on the number of circulating neutrophils present at the time of PDT. Moreover, it has also recently been shown that in addition to local neutrophil accumulation, PDT induces a systemic neutrophil response in treated mice accompanied by the production of a wide variety of molecules (Cecic et al., 2001) . With regard to tumour infiltration, an important step is the migration of leukocytes out of blood vessels. Important molecules involved in this process are ICAM-1, VCAM-1, E-and P-selectins. The expression of these four molecules is under the control of NF-kB. In this work, we showed that NF-kB induced after PDT is translocated into the nucleus and binds to the ICAM-1 and VCAM-1 promoters. We also showed that only the proximal NF-kB binding site of the ICAM-1 promoter is essential for gene transcription. In the present work, we have also shown that PDT of endothelial cells induces the transcription and secretion of IL-6. This is in agreement with the finding of Gollnick et al. (1997) , which have shown a transcription and secretion of IL-6 after PDT in mice. A crucial event for the expression of membrane protein is their export via the ER and Golgi apparatus to reach the plasma membrane. In this paper, we showed that PDT disrupted the ICAM-1 and VCAM-1 expression via their degradation in lysosomes. Similarly, CD44V6, lectins and MHC-I were shown to be transiently downregulated in two colon cancer cell lines after Photofrin or BPD-MA photosensitization (Rousset et al., 1999) . To examine the mechanism of the disruption of CAMs expression, we used several proteases inhibitors. We observed that only a treatment with a cocktail of lysosomal protease inhibitors restored the detection of ICAM-1 and VCAM-1 after PDT. Moreover, using ICAM-1-EGFP transiently transfected cells, we showed that PDT induced a spatial redistribution of lysosomes that converged into intracytoplasmic structures containing ICAM-1-EGFP, while untreated cells exhibited a homogenous cytoplasmic distribution of lysosomes with a plasma membrane-restricted localization of ICAM-1-EGFP. The pretreatment of the cells by several lysosome protease inhibitors restored the plasma membrane expression of ICAM-1-EGFP, while the convergence of lysosomes was could still be observed. This showed that lysosomes were responsible for the CAMs degradation after PDT. Ubiquitination has recently been shown to be important for protein function. Polyubiquitination of proteins leads to their degradation by proteasome 26S. Recently, it was shown that protein mono-ubiquitination could be an internalization signal that targets plasma membrane proteins for entry in the lysosomal pathway (Haglund et al., 2002; Mosesson et al., 2003) . As it has been shown several times that oxidative stress induces the activation of ubiquitin ligase complexes (Jahngen-Hodge et al., 1997; Shang et al., 1997), we tried to visualize ICAM-1 ubiquitination. However, we failed to demonstrate any ICAM-1 mono or polyubiquitination after PDT. Altogether these data indicate that neither poly-nor mono-ubiquitination was responsible for the ICAM-1 targeting to lysosomes. 
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Figure 7 Intracellular membrane oxidation induces ICAM-1 degradation. (a) HMEC-1 cells were treated by PDT (5 mM PPME, 2 J/cm 2 red light irradiation). At 4 h after treatment, cells were incubated with BHA (200 mM), a-Tocopherol acetate (300 mM), or both. Cells incubated with PPME (5 mM) but not irradiated are noted Ctrl. At 24 and 48 h after the treatment, cell lysates were carried out. In total, 20 mg of proteins were analysed by Western blot with specific antibodies for ICAM-1. l.c. represents the loading controls. (b) HMEC-1 cells were treated by PDT (5 mM PPME, 2 J/ cm 2 red light irradiation) or TNF-a (200 U/ml). At 4 h after treatment, cells were incubated with BHT (50 mM) or DBT (50 mM). Cells incubated with PPME (5 mM) but not irradiated are noted Ctrl. At 8, 24 and 36 h after the treatment cell lysates were taken. In total, 20 mg of proteins were analysed by Western blot with specific antibodies for ICAM-1. l.c. represents the loading controls Figure 8 PDT does not induce adhesion of granulocytes to endothelial cells. HMEC-1 cells were untreated (T-), treated by TNF-a (200 U/ml), treated by LPS (10 mg/ml), treated by PPME mediated PDT (5 mM PPME, 2 J/cm 2 red light irradiation) with or without preincubation with leupeptine, pepstatine A and E64 or treated by Photofrin mediated PDT (Photofrin at 10 mg/ml, 1 J/cm 2 irradiation) for 12 h. The cells were then subjected to a granulocyte adhesion assay. Results are expressed as the ratio between granulocytes vs endothelial cells
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While we showed in this work that ICAM-1 and VCAM-1 proteins are degraded by lysosomal proteases, it cannot be excluded that matrix metalloproteinase 9 (MMP-9) and elastase could be implicated in ICAM-1 and VCAM-1 proteolysis. Endothelial cells constitutively express MMP9 (Arkell and Jackson, 2003; Lee et al., 2003) as well as elastase (Santos et al., 2003) . Moreover, these molecules have been shown to cleave both ICAM-1 and VCAM-1 (Levesque et al., 2001; Fiore et al., 2002) . Since ROS triggered NF-kB activation appears to be important for MMP-9 transcription (Kolev et al., 2003) , these proteases could likely be candidates for ICAM-1 and VCAM-1 degradation after PPME mediated PDT. Additional experiments on the release of MMP-9 in culture media after PDT are needed to clarify this point.
An interesting observation made during this work is that the secretion of proteins, which are released in the lumen, such as IL-6, appeared not to be altered by PDT. Since PPME is localized in the ER membrane, a likely possibility could be that ROS generated by PPME induced the oxidation of membrane proteins and therefore impaired the correct cellular targeting of the CAMs (Figure 9 ). This hypothesis is strongly reinforced by the demonstration that membrane-specific antioxidants, such as BHA, BHT or a-tocopherol acetate, partially restored ICAM-1 expression. The major ROS generated by PPME irradiation is singlet oxygen (Ochsner, 1997) . In the lipid bilayer, singlet oxygen could lead to a lipoperoxidation cycle and, therefore, it could be suggested that lipoperoxidation of the ER membrane partially disrupted its integrity influencing the correct insertion of proteins ( Figure 9 ). Our hypothesis for the absence of CAMs expression after PDT mediated by PPME is reinforced by the observation that Photofrin and HPPH (Gollnick et al., 2003) , which are both mitochondria-localized photosensitizers, lead to the correct targeting of these adhesion molecules. Therefore, re-orientation of membrane-associated proteins described in this work should be a particular feature associated with ER/Golgi-bound photosensitizers such as PPME.
Materials and methods
Chemicals and reagents PPME was from Sigma (Bornem, Belgium). A stock solution was made in ethanol. Photofrin was a donation from C VeverBizet (Paris, France) and was dissolved in 5% dextrose in water to make a 2.5 mg/ml stock solution. All other reagents were reagent grade.
Light source
The light source used was a halogen lamp combined with a red filter (l>600 nm) giving a fluence rate of 160 W/m 2 .
Plasmids
ICAM-1 promoter constructs were a donation from Dr Y de Launoit (University of Brussels, Belgium). pBJ1 Neo ICAM-1 EGFP construct was kindly provided by Dr MM Davis (Stanford University School of Medecine) (Wulfing et al., 1998) .
Cell culture
The human dermal microvascular cell line HMEC-1 was cultured as described in our previous paper (Volanti et al., 2002) . HeLa cells were cultured in DMEM culture medium (GIBCO, Merelbeke, Belgium) supplemented with 10% FCS and glutamine.
Cell exposure to PPME photosensitization Cell exposure to PPME photosensitization was performed as described in Volanti et al. (2002) . 
Protein extraction
Cells were washed twice in cold PBS, scraped in cold PBS and centrifuged at 3000 Â g for 2 min. Cells were resuspended in 1 ml of cold PBS and centrifugated at 3000 Â g for 2 min. The pellets were then resuspended in 50 ml of cold RIPA buffer (30 mM phosphate, 137 mM NaCl, 1% IGEPAL, 0.5% DOC, 1% SDS, 5 mM EDTA, 1 mM DTT, 1 mM PMSF and Complett, pH 7.4) and left on ice for 20 min before vortexing 10 s and left on ice for a further 20 min. The samples were centrifuged at 15 000 Â g for 30 min at 41C and supernatants containing total proteins were stored at À801C. Protein concentrations were measured with the Micro BCA protein assays kit (Pierce, UK).
Electrophoretic mobility shift assays
Nuclear extracts were obtained as described above. EMSA was performed as described in our previous paper (Volanti et al., 2002) . DNA-protein complexes were resolved in a nondenaturing 6%, or 4% for supershift experiments, (w/v) polyacrylamide gel run for 3 h at 300 V in 0.25 M Tris, 0.25 M sodium borate, and 0.5 mM EDTA, pH 8.0.
Transient transfection assays
HMEC-1 cells were cultured to a confluence of about 80. At 48 h before transfection, culture medium were replaced by RPMI 1640 supplemented with 15% FCS and ultraglutamine. Cells were transfected with FugeneVI liposome methods (Boehringer, Mannheim, Germany) following the manufacturer's recommendation.
IL-6 detection
The release of IL-6 from HMEC-1 cells into the culture medium after photosensitization or treatment with LPS or TNF-a was quantitatively assayed by a double antibody ELISA kit using recombinant IL-6 as standard (ELISA, CYTOScreen, Biosource, Nivelles, Belgium), according to the manufacturer's recommendation. This assay has a detection limit of 5 pg/ml. Results are expressed as the mean of five separate experiments.
mRNA expression studies
Cells were washed twice in cold PBS, scraped in cold PBS and centrifuged at 3000 Â g for 2 min and directly frozen at À801C. Total mRNAs were obtained using the TRIPUR extraction kit (Roche, Mannheim, Germany). To avoid all DNA contamination, RNAs were treated with DNAse I (Roche, Mannheim, Germany) for 20 min at 371C in DNAse I buffer (100 mM Tris, 100 mM MgCl 2 , pH 7.6). A total of 1 mg of RNAs was then subjected to a reverse-transcription in 15 ml reaction mixture containing 2.5 mM random primers (Amersham Pharmacia Biotech), 16 mM DTT (Life Technologies, Carlsbad, CA, USA), 1.6 mM dNTPs (Roche, Mannheim, Germany), 0.35 ml RNA guard (Amersham Pharmacia Biotech), 250 U of Moloney-murine-leukemia virus reverse transcriptase (Life Technologies, Carlsbad, CA, USA) and first-strand buffer (Life Technologies).
Western blotting
ICAM-1 and VCAM-1 were detected by Western blot analysis using specific antibodies. SDS-PAGE and blotting were performed as described in Volanti et al. (2002) .
Granulocytes adhesion assay
Granulocytes were isolated from human blood using histopaque-1077 (Sigma, Belgium). After a centrifugation of 400 Â g for 30 min at room temperature, plasma, mononuclear cells and histopaque were eliminated. Granulocytes and erythrocytes were incubated with the haemolysis buffer (0.15 M NH 4 Cl, 0.01 M KHCO 3 , 0.1 mM EDTA, pH 7.5) for 7 min at room temperature. Solutions were then supplemented (v/v) with PBS-FBS (PBS, 20% FBS) and centrifuged for 10 min at 500 Â g. This step was repeated two times. Granulocytes were then resuspended in RPMI 15% FBS and added to HMEC-1 cells cultivated at 90% of confluence, and photosensitized 12 h before. The ratio of granulocytes vs HMEC-1 was 10/1. HMEC-1 was stained with Cell Tracker Green CMFDA (Molecular Probes, Leiden, The Netherlands) 2 h before the addition of granulocytes. Granulocytes and HMEC-1 were incubated together for 1 h. Cells were then washed 3 times with PBS-FBS and trypsinized. Isolated cells were resuspended in PBS-FBS and the ratio between HMEC-1 and granulocytes was determined by flow cytometry. The ratio between unlabelled (granulocytes) and green cells (HMEC-1) was calculated on 20 000 analysed cells.
Immunofluorescence HMEC-1 cells were cultivated and treated on coverslips. Cells were fixed and permeabilized by a 20-min treatment of cold acetone/methanol (v/v). Cells were blocked 30 min in PBS 1.5% dry milk and incubated overnight with ICAM-1 antibody (1 : 200 dilution, Santa Cruz Biotechnology, USA) or with VCAM-1 antibody (1 : 100 dilution, Santa Cruz Biotechnology, USA) in PBS 1.5% dry milk at 41C. Cells were washed with PBS and incubated 45 min at 371C with rabbit anti-mouse FITC conjugated antibody for ICAM-1 and VCAM-1 localization. Cells were observed with a Nikon eclipse e800 epifluorescence microscope.
Confocal laser microscopy
HeLa cells were cultured on coverslips and transiently transfected by Fugene VI liposome (Boehringer, Mannheim, Germany) following the manufacturer's recommendation with 1 mg of pBJ1 neo ICAM-1 EGFP construct. At 1 h before being fixed with para-formaldehyde at 4% and mounted on glass slides, cells were incubated with 50 nM LysoTracker Red (Molecular Probes, The Netherlands). Cells were analysed by confocal laser microscopy (Leica TCS NT, Japan).
luene; DBT, 3,5-di-tert-butyltoluene; l.c., loading control; n.s., nonspecific.
